Skip to main content


Xenoport's cost-cutting tactics lead to buyout with hefty premium

The biotechnology company, which makes alcoholism drug Horizant, was acquired by privately held Arbor Pharmaceuticals for $467 million in cash, a price lower than at least one analyst expected.

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

XenoPort (XNPT) shares are soaring Monday as Arbor Pharmaceuticals agreed to acquire the company in a deal valued at about $467 million.

XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million

XenoPort (XNPT) shares are soaring Monday on the announcement that Arbor Pharmaceuticals will buy the biopharmaceutical company in a deal valued at about$467 million.

5 stocks insiders love right now

Insiders at these companies have been scooping up shares of their own stock lately.

XenoPort (XNPT) Stock Advancing on Potential Sale

XenoPort (XNPT) stock is gaining on Friday morning as the company explores the possibility of selling its self.

Breaking News

Billionaire Gautam Adani Loses $26 Billion in 3 Days

The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.

FTX: DOJ Seeks to Ban Bankman-Fried From Using Signal, Slack to Contact Employees

The Justice Department wants to ban Sam Bankman-Fried, the former CEO of bankrupt FTX, from speaking to former employees of the crypto exchange.

Elon Musk Has Questions About the War in Ukraine

The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.

A Royal Caribbean Cruise Line Adult Favorite Has Not Come Back

The cruise line has almost fully returned to normal after the covid pandemic, but one very popular activity hasn't been brought back.